parecoxib has been researched along with telmisartan in 1 studies
| Studies (parecoxib) | Trials (parecoxib) | Recent Studies (post-2010) (parecoxib) | Studies (telmisartan) | Trials (telmisartan) | Recent Studies (post-2010) (telmisartan) |
|---|---|---|---|---|---|
| 436 | 186 | 229 | 1,930 | 480 | 1,038 |
| Protein | Taxonomy | parecoxib (IC50) | telmisartan (IC50) |
|---|---|---|---|
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.42 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0179 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0003 | |
| Cytochrome P450 2J2 | Homo sapiens (human) | 0.5 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.2589 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.8621 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, Y; Körbel, C; Laschke, MW; Menger, MD; Nenicu, A | 1 |
1 other study(ies) available for parecoxib and telmisartan
| Article | Year |
|---|---|
Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Caspase 3; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Therapy, Combination; Endometriosis; Female; Isoxazoles; Matrix Metalloproteinase 9; Mice, Inbred C57BL; PPAR gamma; Proto-Oncogene Proteins c-akt; Telmisartan; Ultrasonography | 2017 |